photo of

Details

Role Group Leader
Group SAEFVIC

Contact

Professor Crawford is a consultant paediatrician and vaccinologist, he is also recognised as an expert in vaccination of special risk groups. He is the Director of SAEFVIC (Surveillance of Adverse Events Following Vaccination In the Community) the Victorian Safety Service and the Melbourne Vaccine Education Centre (MVEC) where he leads a team of more than 30 staff members. Prof Crawford is Head of Immunisation Services at The Royal Children’s Hospital (RCH) and Chair of the Victorian Specialist Immunisation Services (VicSIS).

In 2021, Prof Crawford was appointed the Chair of the Australian Therapeutic Advisory Group on Immunisation (ATAGI), Ex-officio Member of COVID-19 Vaccines and Treatments for Australia – Science and Industry Technical Advisory Group (SITAG), Member of Department of Foreign Affairs and Trade (DFAT) COVID-19 vaccine Expert Advisory Group (EAG), Member of the Victorian Department of Health, COVID-19 vaccine Expert Advisory Group (EAG), member of Vaccination Special Interest Group (VACSIG)/ Australasian Society for Infectious Diseases (ASID), and the Victorian representative of TGA-JIC (Jurisdictional Immunisation Co-ordinators) vaccine safety meetings with Australian Government Department of Health. Internationally, Prof Crawford is the founding/steering committee member of the International Specialist Immunisation Services (InSIS) network in Canada, a member of the World Health Organisation (WHO), Geneva and most recently appointed as the WPRO (Western Pacific Region) Representative of the GNN (Global NITAG Network) steering committee in WHO Geneva.
Professor Crawford is a consultant paediatrician and vaccinologist, he is also recognised as an expert in vaccination of special risk groups. He is the Director of SAEFVIC (Surveillance of Adverse Events Following Vaccination In the Community) the...
Professor Crawford is a consultant paediatrician and vaccinologist, he is also recognised as an expert in vaccination of special risk groups. He is the Director of SAEFVIC (Surveillance of Adverse Events Following Vaccination In the Community) the Victorian Safety Service and the Melbourne Vaccine Education Centre (MVEC) where he leads a team of more than 30 staff members. Prof Crawford is Head of Immunisation Services at The Royal Children’s Hospital (RCH) and Chair of the Victorian Specialist Immunisation Services (VicSIS).

In 2021, Prof Crawford was appointed the Chair of the Australian Therapeutic Advisory Group on Immunisation (ATAGI), Ex-officio Member of COVID-19 Vaccines and Treatments for Australia – Science and Industry Technical Advisory Group (SITAG), Member of Department of Foreign Affairs and Trade (DFAT) COVID-19 vaccine Expert Advisory Group (EAG), Member of the Victorian Department of Health, COVID-19 vaccine Expert Advisory Group (EAG), member of Vaccination Special Interest Group (VACSIG)/ Australasian Society for Infectious Diseases (ASID), and the Victorian representative of TGA-JIC (Jurisdictional Immunisation Co-ordinators) vaccine safety meetings with Australian Government Department of Health. Internationally, Prof Crawford is the founding/steering committee member of the International Specialist Immunisation Services (InSIS) network in Canada, a member of the World Health Organisation (WHO), Geneva and most recently appointed as the WPRO (Western Pacific Region) Representative of the GNN (Global NITAG Network) steering committee in WHO Geneva.

Top Publications

  • Begum, H, Dwyer, DE, Holmes, M, Irving, L, Simpson, G, Senenayake, S, Korman, T, Friedman, ND, Cooley, L, Wark, P, et al. Surveillance for severe influenza and COVID-19 in patients admitted to sentinel Australian hospitals in 2020: the Influenza Complications Alert Network (FluCAN).. Communicable Diseases Intelligence 46: 2024
    view publication
  • Cheng, AC, Dwyer, DE, Holmes, M, Irving, L, Simpson, G, Senenayake, S, Korman, T, Friedman, ND, Cooley, L, Wark, P, et al. Influenza epidemiology in patients admitted to sentinel Australian hospitals in 2019: the Influenza Complications Alert Network (FluCAN).. Communicable Diseases Intelligence 46: 2024
    view publication
  • F, JDL, Awad, A, Vogrin, S, P, AD, Lutjen, A, F, SG, Crawford, N, Barnes, S, Trubiano, J. Safety of COVID-19 vaccine challenge in patients with immediate adverse reactions to prior doses - A multicentre cohort study. 2024
    view publication
  • Eden, J-S, Sikazwe, C, Xie, R, Deng, Y-M, Sullivan, SG, Michie, A, Levy, A, Cutmore, E, Blyth, CC, Britton, PN, et al. Off-season RSV epidemics in Australia after easing of COVID-19 restrictions. Nature Communications 13(1) : 2884 2024
    view publication
  • Villanueva, P, Wadia, U, Crawford, NW, Messina, NL, Kollmann, TR, Lucas, M, Manning, L, Richmond, P, Pittet, LF, Curtis, N. The safety of co-administration of Bacille Calmette-Guérin (BCG) and influenza vaccines. PLOS ONE 17(6) : e0268042 2024
    view publication

Page 6 of 44